Exited 1,107,504 shares; estimated trade size $17.81 million (based on quarterly average price)
Quarter-end position value declined by $17.81 million, reflecting both the sale and market price movement
Post-trade stake: zero shares, zero value
On February 2, 2026, AIGH Capital Management LLC fully exited its stake in MaxLinear (NASDAQ:MXL), selling 1,107,504 shares in a transaction estimated at $17.81 million based on quarterly average pricing.
According to a Securities and Exchange Commission (SEC) filing dated February 2, 2026, AIGH Capital Management LLC reported selling all 1,107,504 shares of MaxLinear during the fourth quarter. The estimated transaction value was $17.81 million, based on the average closing price for the period. The fund’s reported quarter-end position value in MaxLinear fell to zero, with the change reflecting both the trade and any price movement during the quarter.
| Metric | Value |
|---|---|
| Price (as of market close 2/1/26) | $17.35 |
| Market Capitalization | $1.51 billion |
| Revenue (TTM) | $467.64 million |
| Net Income (TTM) | ($136.68 million) |
MaxLinear, Inc. is a technology company specializing in advanced semiconductor solutions that integrate RF, analog, and digital functions for communications and networking applications. The company leverages its expertise in mixed-signal and system-on-chip design to address demanding requirements in broadband, wireless, and data center markets. Its competitive edge is driven by highly integrated products that enable efficient, high-performance connectivity for a diverse customer base worldwide.
Everyday investors could take AIGH Capital’s sale of MaxLinear shares as a sign the firm isn’t satisfied with the underlying business. The firm closed out over a dozen positions during the fourth quarter of 2025, and MaxLinear was largest it let go of.
Everyday investors could also look at AIGH’s sale of MaxLinear as a repositioning of the portfolio towards the biopharmaceutical industry. During the fourth quarter, AIGH Capital added several relatively large positions in companies that develop new drugs.
MaxLinear stock has risen just 1.2% since the end of the fourth quarter of 2025. Despite the paltry stock price appreciation, the fourth-quarter results the company released on Jan. 29, 2026, probably made AIGH Capital wish it were still holding the stock. Net revenue soared by 48% year over year and by 8% since the third quarter. On an adjusted basis, the company reported earnings that rose to $0.19 per share from a loss of $0.09 in the previous year period.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 942%* — a market-crushing outperformance compared to 196% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of February 2, 2026.
Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Zoom Communications. The Motley Fool has a disclosure policy.